Compare Martina Berto Tbk. (MBTO) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Martina Berto Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Martina Berto Tbk. trades at Rp168 (market cap 150.87B, 147.57M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Martina Berto Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| MBTO | SCPI | |
|---|---|---|
Market Cap | 150.87B | 104.4B |
Volume | 147.57M | — |
Lot | 1.48M | — |
Turnover | 24.01B | — |
Average Price | 162.68 | — |
Value | 24.01B | — |
Indicative Equilibrium Price | 168 | — |
Indicative Equilibrium Volume | 76.3K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Martina Berto Tbk.
PT Martina Berto Tbk (the Company) was established in the Republic of Indonesia on 1 June 1977 based on Notarial deed No. 9 of Poppy Savitri Parmanto, S.H. In 1977, PT Matina Berto stands as a home industry with product branded Sariayu. In 1981, the company established the first modern factory on Pulo Ayan, Pulogadung Industrial Estate. In 1986, the second factory was established on Pulo Kambing, Pulogadung Industrial Estate. In 1993, the company acquired cosmetics factory PT Cedefindo as contract manufacturing for internal & external. In 1995, PT Martina Berto III was established in Gunung Putri, Bogor.The Company’s articles of association has been amended several times, most recently by notarial deed No.9 of Yanto W, S.H., dated Sep 27 2010, concerning among others, change in par value, and public offering.
Read more on MBTO →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
